{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:29:00Z","timestamp":1790688540484,"version":"4.1.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.mayocp.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T02:53:58Z","timestamp":1756004038000},"page":"1846-1847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adult Case of Toxic Erythema of Chemotherapy Mimicking Toxic Epidermal Necrolysis in a Patient on Enfortumab Vedotin and Pembrolizumab"],"prefix":"10.1016","volume":"100","author":[{"given":"Jared S.","family":"Kahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-8391","authenticated-orcid":false,"given":"Alina G.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2025.05.003_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hemonc.2018.09.001","article-title":"Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation","volume":"12","author":"Hunjan","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"7","key":"10.1016\/j.mayocp.2025.05.003_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ijd.14392","article-title":"Chemotherapy-induced skin toxicity and capillary leak syndrome","volume":"58","author":"Hunjan","year":"2019","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2025.05.003_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mayocp.2025.05.003_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.801199","article-title":"Cutaneous toxicity associated with enfortumab vedotin: a real-word study leveraging US Food and Drug Administration adverse event reporting system","volume":"11","author":"Yang","year":"2022","journal-title":"Front Oncol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T23:26:31Z","timestamp":1759965991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619625002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":4,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0025619625002666"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.05.003","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult Case of Toxic Erythema of Chemotherapy Mimicking Toxic Epidermal Necrolysis in a Patient on Enfortumab Vedotin and Pembrolizumab","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}